Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Cross-ancestry genome-wide polygenic score predicts chronic kidney disease

A new genome-wide polygenic risk score for chronic kidney disease (CKD) that combines APOL1 risk genotypes with polygenic effects was validated in 15 diverse cohorts. The top 2% of the score reproducibly conveyed a threefold higher risk of CKD across all ancestries, a degree of risk that is equivalent to a positive family history of kidney disease.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Estimated risk effects of a genome-wide polygenic score for CKD.


  1. Wuttke, M. et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 51, 957–972 (2019). Discovery GWAS for renal function used to derive the polygenic component of the score for CKD.

    CAS  Article  Google Scholar 

  2. Parsa, A. et al. APOL1 risk variants, race, and progression of chronic kidney disease. N. Engl. J. Med. 369, 2183–2196 (2013). Demonstration of the effects of APOL1 on the risk of kidney disease progression.

    CAS  Article  Google Scholar 

  3. Wand, H. et al. Improving reporting standards for polygenic scores in risk prediction studies. Nature 591, 211–219 (2021). ClinGen standards for reporting polygenic risk scores in risk-prediction studies.

    CAS  Article  Google Scholar 

  4. Shang, N. et al. Medical records-based chronic kidney disease phenotype for clinical care and “big data” observational and genetic studies. NPJ Digit. Med. 4, 70 (2021). Design and validation of a portable and scalable e-phenotype for CKD diagnosis and staging.

    Article  Google Scholar 

  5. Neugut, Y. D. et al. Cases in precision medicine: APOL1 and genetic testing in the evaluation of chronic kidney disease and potential transplant. Ann. Intern. Med. 171, 659–664 (2019). An article from the ‘Cases in Precision Medicine’ series discussing APOL1 testing in the setting of CKD and kidney transplantation.

    Article  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Khan, A. et al. Genome-wide polygenic score to predict chronic kidney disease across ancestries. Nat. Med. (2022).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cross-ancestry genome-wide polygenic score predicts chronic kidney disease. Nat Med (2022).

Download citation

  • Published:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing